Abstract. We have previously reported that the enhancement of free radical generation in mitochondria isolated from the kidney cortex of rats exposed to cephaloridine (CER) is probably mediated by the activation of protein kinase C (PKC). We examined which isoenzymes of PKC might be involved in the development of nephrotoxicity induced by CER in rats. The CERinduced renal dysfunction observed 24 h after its injection was prevented by a potent antioxidant DPPD and well-known PKC inhibitors like H-7 and rottlerin. At 1.5 and 3.5 h after the CER injection, the free radical generation was increased markedly and this was associated with translocation of PKCδ into the mitochondria of renal cortex tissue. Pretreatment of rats with H-7, a PKC inhibitor, significantly inhibited the CER-derived increase in mitochondrial generation of free radicals, suggesting that H-7 probably gets into the mitochondria and inhibits the activity of translocated PKC within the mitochondria. It was also shown that pretreatment of rats with rottlerin, a specific inhibitor of PKCδ, suppressed the early translocation of PKCδ into mitochondria and inhibited the CER-derived development of renal dysfunction. These results suggest that the CER-derived early translocation of PKCδ into mitochondria probably leads to the enhanced production of free radicals through the mitochondrial respiratory chain during the development of the nephrotoxicity caused by CER. Understanding the role of PKCδ in mitochondria may provide an important clue to the molecular mechanisms of mitochondrial production of reactive oxygen species and the free radical-induced renal failure in rats treated with CER.
Introduction
Cephaloridine (CER), a β-lactam antibiotic, has been proven to be nephrotoxic and has been reported to cause acute renal failure as a side effect in humans as well as experimental animals (1 -3) . Renal damage due to CER administration is characterized by acute proximal tubular necrosis, most notably the S2 segment of the tubules (4) , where CER is transported by the renal basolateral transport system for organic anions from the blood to the proximal tubular cells (5) . However, CER is limited in its movement to the tubular lumen, resulting in its high concentration within the proximal tubular cells, leading to the development of progressive renal disease (6 -8) . Evidence has been provided that reactive oxygen species (ROS) and the peroxidation of cell membrane lipids are involved in the development of the nephrotoxicity induced by CER (9 -12) . We have previously demonstrated that free radical-mediated injury induced by CER is enhanced by phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, in rat renal cortical slices (13) . We have also reported that PKC activation, via the translocation of PKC from the cytosol into the mitochondria, is involved in free radical-induced CER nephrotoxicity in rats (14) . Vonruecker et al. have recently shown that PKC is important for mediating cell injury and modulating lipid peroxidation in hepatocytes exposed to ROS (15) . Several studies have indicated that mitochondria are one of the sites of free radical generation such as ROS in renal injuries induced by some nephrotoxicants (16, 17) .
The PKC family is composed of at least 11 serine / threonine kinases, which are grouped according to the biochemical requirement for their activation (18) . PKC isoenzymes are expressed in a tissue-specific fashion and their subcellular localization varies depending on the cell types (19) . It has been reported that PKC α, β, δ, and ζ isoenzymes are expressed in the rat kidney (20) .
Here, we investigated which of these PKC isozymes of PKC might be involved in the CER-derived nephrotoxicity. Results show that CER induces the translocation of PKCδ, an isozyme of PKC, into the mitochondria of tubular cells in the kidney cortex and enhances the mitochondrial production of free radicals.
Materials and Methods

Chemicals
CER was supplied from Shionogi & Co., Ltd. (Osaka). The antioxidant N,N'-diphenyl-p-phenylenediamine (DPPD) and the cypridina luciferin analog 2-methyl-6-phenyl-3,7-dihydro-imidazo [ (23) . An antibody specific against the PKCδ isoenzyme was purchased from BD Transduction Laboratories (Lexington, KY, USA). All other chemicals used were of the highest purity available (Wako Pure Chemical Industries, Ltd., Osaka).
Experimental animals
Specific pathogen-free male Sprague-Dawley rats weighing 180 to 230 g were used to develop CERinduced acute renal failure. The animals were allowed free access to tap water and a standard laboratory diet. The animals were given 1.2 g / kg of CER dissolved in isotonic saline by intravenous injection. Control animals were administered the same volume of isotonic saline. The animals were sacrificed under pentobarbital anesthesia (50 mg / kg, i.p.) and their kidneys were removed 1.5, 3.5, and 24 h after the injections. Blood samples were collected at the above times for determination of the plasma creatinine and urea nitrogen concentrations by a colorimetric method using a spectrophotometer.
Electron microscopy
Transverse sections of the kidney cortex were minced into 1 mm 3 cubes at 24 h after treatment with CER. For electron microscopy, the sections were fixed in 2.5% glutaraldehyde and 1% formaldehyde in 0.1 M PBS (pH 7.4) and refrigerated for up to 24 h. Samples were postfixed in 1% osmium tetroxide in 0.1 M phosphate buffer, dehydrated through a graded series of ethanol and propylene oxide, and then embedded in epoxy resin. Semithin sections of approximately 1-µm thickness were cut with glass knives and stained with toluidine blue. After areas of interest were identified, ultrathin sections were cut with diamond knives and stained with 1% uranyl acetate for 20 min and 1% lead citrate for 2 min. Electron microscopic findings were obtained and photographed using a HITACHI H-600 transmission electron microscope (Hitachi, Tokyo).
Preparation of the mitochondrial and cytosolic fractions
Mitochondrial fractions were prepared from the kidney cortex of rats treated with CER by a modification of the method (24, 25) of Greenawalt and Schnaitman (26) . Kidneys were placed in ice-cold buffer A, which consisted of 0.25 M sucrose, 3 mM MgCl 2 , 25 mM β-glycerophosphate, 1 mM dithiothreitol, 1 mM orthovanadate, and protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 µg / ml aprotinin, 1 µg/ ml leupeptin, and 1 µg/ ml pepstatin). The kidneys were homogenized at 0°C in a glass homogenizer and centrifuged at 850 × g for 10 min at 4°C. The resultant supernatants were recentrifuged at 850 × g for 10 min at 4°C, yielding second supernatants that were then centrifuged at 10,000 × g for 10 min at 4°C. This supernatant (S1) was used for the preparation of the cytosolic fraction. The resultant pellets were suspended in buffer A and recentrifuged at 10,000 × g for 10 min at 4°C. The precipitate was resuspended in buffer A to be used as the mitochondrial fractions. A part of the mitochondrial pellets was disrupted in lysis buffer for 30 min on ice. Its supernatant was used as the soluble mitochondrial fraction. The supernatant (S1) obtained by centrifugation at 10,000 × g for 10 min at 4°C was then centrifuged at 100,000 × g for 1 h at 4°C. The resultant supernatant was used as the soluble cytosolic fraction. The PIERCE protein estimation kit was used to determine the protein concentration with bovine serum albumin as a standard.
Measurement of reactive oxygen radical generation in mitochondria
Generation of ROS was measured as the chemiluminescence (CL) amplified by cypridina luciferin analog (CLA)-dependent CL, which is dependent on O 2
• − generation. The mitochondria were suspended in Hanks' buffer. CLA-dependent CL was measured by the method previously described (21, 22) . CLA was added to the sample tubes containing the mitochondrial fractions in Hanks' buffer. The CL of each mitochondria fraction was measured using a Luminescence Reader (CAF-110; Jasco, Tokyo). CLA-dependent CL was assessed with the peak value of CL as counts / mg protein.
Electrophoresis and Western blot analysis
The soluble proteins (5 µg protein) of mitochondrial and cytosolic fractions were separated by 10% SDSpolyacrylamide gel electrophoresis (SDS-PAGE). The proteins were transferred to nitrocellulose membranes. The membranes were blocked in 3% bovine serum albumin (BSA) in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 0.1% Tween 20 (TBST) overnight at 4°C and then incubated with the primary antibody specific against the PKCδ isoenzyme in 1% BSA-TBST for 30 min at 37°C. The membranes were washed three times in BSA-TBST to remove the unbound antibodies and then incubated with alkaline phosphatase-conjugated secondary antibody in 1% BSA-TBST for 30 min at 37°C. Enhanced chemiluminescence (ECL) Western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA) were used for detecting the immunoreactive bands of PKCδ.
Statistical analyses
All data are expressed as means ± S.E.M. Statistical analysis of the data from multiple groups was performed by ANOVA followed by Scheffe's F tests. P values less than 0.05 were considered to reflect a significant difference.
Results
Induction of acute renal failure by CER administration
Acute renal failure was induced by 24 h after the CER (1.2 g / kg, i.v.) administration. Blood urea nitrogen (BUN) levels were significantly higher in the CERadministered rats compared with those of normal controls (Fig. 1A) . Plasma levels of creatinine were also higher in the CER-administered rats than in normal controls (Fig. 1B) . The levels of BUN and plasma creatinine were unchanged at 1.5 and 3.5 h after CER treatment (data not shown). The pattern of change in BUN levels closely paralleled that of the changes in creatinine seen after treatment with CER.
Pathologic expression resulting from CER administration in the rat kidney was verified with electron microscopy. There were no changes in the electron micrographs of the renal proximal tubules of rats at 1.5 h after treatment with CER (data not shown). However, electron micrographs showed a marked dilation of the vacuolar apparatus, swollen mitochondria, and loss of the microvillus border in the proximal tubules at 24 h after the CER exposure (Fig. 3B) .
Effect of DPPD administration in CER-treated rats
Protective effect of DPPD, an antioxidant, against the CER-inducible nephrotoxicity was tested. Pretreatment with DPPD (0.5 g / kg, i.p.) at 2 h before the CER injection significantly decreased the CER-induced increases in BUN levels (Fig. 1A) and plasma creatinine levels (Fig. 1B ) normally seen at 24 h after the CER injection. No significant differences in BUN and plasma creatinine levels were observed after the injection of DPPD alone.
Effect of the PKC inhibitors, H-7 and rottlerin, in CERinduced nephrotoxicity
Compared with those in the saline-treated control group, the rats in the CER-treated group showed significant elevations of BUN and plasma creatinine levels at 24 h after the CER injection. Pretreatment of rats with PKC inhibitors, H-7 or rottlerin, 0.5 h before the CER injection prevented the increases in BUN and plasma creatinine levels (Fig. 2) . None of the changes were significantly different from those observed in rats given H-7 or rottlerin alone. H-7 also attenuated the CERinduced changes in ultrastructural morphology, indicating that the renal dysfunction caused by CER treatment in rats was caused by activation of PKC (Fig. 3C) . Treatment with H-7 alone did not affect renal function (Fig. 3D) . Effect of the PKC inhibitor H-7 on CER-induced mitochondrial free radical generation as assessed by CLA-dependent CL Maximal increase of CLA-dependent CL intensity was detected in the mitochondria prepared from kidney cortex of rats at 1.5 h after the CER administration. CLA-dependent CL intensity in mitochondria decreased by 3.5 h after the CER injection, but the CL intensity was still significantly higher than that observed in the mitochondria prepared from saline-treated control rats (Fig. 4) . Such increases of CLA-dependent CL intensity in mitochondria were reduced to control levels in the presence of superoxide dismutase (14) . The PKC inhibitor H-7 significantly suppressed the CER-dependent increase in CL intensity of CLA (Fig. 4) . In the microsomes prepared from kidney cortex of rats treated with CER, however, there were no significant differences in the CLA-dependent CL intensity (14) .
Effect of the selective PKCδ inhibitor rottlerin on CERinduced translocation of PKCδ into mitochondria
To investigate the effect of CER on the intracellular distribution of PKCδ, mitochondria and cytosol proteins prepared from the kidney cortex of rats treated with CER were subjected to Western blotting with anti-PKCδ. Results showed that the decrease in cytosolic PKCδ expression was associated with a concomitant increase of mitochondrial PKCδ at 1.5 and 3.5 h after the CER treatment (Fig. 5A) .
To determine the effect of a selective PKCδ inhibitor on CER-induced translocation of PKCδ into mitochondria, we treated rats with rottlerin. Observed results demonstrated that rottlerin attenuated the CER-induced translocation of PKCδ into mitochondria (Fig. 5B) . Treatment with rottlerin alone did not affect the intracellular distribution of PKCδ in the kidney cortex.
Discussion
This study investigated the role of mitochondrial translocation of PKCδ and free radical generation in mitochondria in causing CER-induced nephrotoxicity. In the present study, a high dose of CER (1.2 g / kg, i.v.) was used to induce renal dysfunction demonstrable with ultrastructural changes at 24 h after the CER treatment in rats. We and others have previously demonstrated that antioxidants effectively inhibited renal cell injury caused by CER, suggesting that ROS mediates the CERinduced renal damage (9 -12, 27) . The in vivo results obtained in this study are in agreement with the suggestion (Fig. 1) . Previous studies have also shown that CER treatment is associated with a decrease in cytosolic PKC activity and a concomitant increase in the mitochondrial PKC in rat renal cortex, indicating that cytosolic PKC translocated into mitochondria in the kidney cortex of rats treated with CER (14) . Moreover, it has been demonstrated that mitochondrial generation of free radicals is associated with CER-derived nephrotoxicity in rats (14) . This was confirmed again in this study (Fig. 4) . Furthermore, we demonstrate in the present study that increased generation of ROS normally seen in the mitochondria of kidney cortex at 1.5 and 3.5 h after injection of CER was completely inhibited by the wellknown PKC inhibitor H-7 (Fig. 4) . It is likely that H-7 gets into the mitochondria and inhibits the activity of translocated PKCδ within the mitochondria. The protective effect of H-7 was evident by its prevention of CERinduced renal dysfunction (Figs. 2 and 3) . Results of our experiments showed further that pretreatment with DPPD (an antioxidant) or rottlerin (a selective inhibitor of PKCδ activity) could suppress the CER-inducible increase of mitochondrial ROS production in the rat renal cortex at 1.5 and 3.5 h after the CER administration. These findings suggest that mitochondrial generation of ROS during the early hours after the CER administration is responsible for the CER-derived nephrotoxicity and this is probably due to activation of the translocated PKCδ activity. If the mitochondrial overproduction of superoxide anion contributes to the CER-induced renal dysfunction, the electron transport flow system of mitochondria may serve as the primary target of PKCδ translocated into the mitochondria.
The PKC family plays important roles in cell functioning (28) . For example, the activation of PKC or enhanced PKC activity is known to be involved in the enhanced generation of ROS in leukocytes (29) . Recently, it has been reported that many PKC isoenzymes are expressed in the kidney. Among them, α, β, δ, ε, and ζ isoenzymes are expressed in the rat kidney cortex (20) . Pfaff et al. have demonstrated the presence of PKCα, β1, and β2 in the rat kidney cortex (30) . We have demonstrated previously that at 1.5 and 3.5 h after treatment of rats with CER, the mitochondrial PKC activity of rat renal cortex is increased significantly and this was associated with a significant decrease of cytosolic PKC activity (14) . This suggested that CER induces the translocation of PKC from cytosol into the mitochondrial compartment. In attempts to confirm the suggestion made in our previous study (14) , we employed rottlerin, a selective inhibitor of PKCδ activity. The results of the present study indicated that rottlerin prevented both the CER-induced translocation of PKCδ into mitochondria and the mitochondrial PKC activity (Fig. 5) . This was associated with a significant decrease of CER-derived nephrotoxicity (Fig. 2) . Thus, it appeared that rottlerin inhibits the translocation of cytosolic PKC into mitochondria, leading to the inhibition of PKC activity and overproduction of ROS by the mitochondria. It seemed that rottlerin inhibited not only the translocation of PKCδ into mitochondria but also the concomitant increase in the mitochondrial PKCδ activity. In contrast to the translocation of PKCδ, PKCα or PKCβ was not present in the mitochondrial fraction prepared from rat renal cortex following the CER treatment.
The exact mechanisms by which the CER induces translocation of PKCδ into mitochondria and enhance mitochondrial generation of ROS remain to be clarified. The translocated PKCδ is suggested to increase the phosphorylation of mitochondrial proteins. In support of this suggestion, Tune et al. have demonstrated that mitochondrial function of rat renal cortex is rapidly influenced by CER (31) . Interestingly, previously published studies have reported that CER might modify complex I and complex II of the mitochondrial electrontransport chain subunit (32). Paddenberg et al. have recently shown that mitochondrial complex II plays an essential role in hypoxic ROS production in the pulmonary vasculature (33) . It has been reported that PKCδ targets mitochondria and induces alterations in the mitochondrial electron transport system in keratinocytes (34) . We hypothesize that the protein of mitochondrial electron transport complexes becomes phosphorylated by the transolcated PKCδ, resulting in enhancement of the mitochondrial ROS production, leading to leakage of electrons from the electron-transport flow system.
It has been demonstrated that PMA, an activator of PKC, induces the translocation of PKCδ from the cytosol to mitochondria in human leukemia cells (35) . Recent studies have revealed that PKCδ localizes in mitochondria in response to oxidative stress (36) . The present findings, considered together with those mentioned above, indicate that the early translocation and activation of mitochondrial PKCδ probably plays a significant role in free radical generation induced by CER via phosphorylation of the mitochondrial electrontransport chain proteins in the kidney.
It has been reported that both PKCδ activation and intracellular distribution of PKCδ may have significant impact on apoptosis (37) . We have hypothesized that the translocation of PKCδ into mitochondria may play a critical role not only in the CER-induced mitochondrial ROS generation but also in the ROS-dependent apoptosis causing the renal dysfunction. It has been suggested that the functional outcome of renal tubular tissues caused by nephrotoxicants is likely to be dependent on both the nature and the severity of cell injury (38) . It has also been demonstrated that while the insult of a mild form can lead to apoptosis causing slow development of renal dysfunction, a severe one can lead to necrosis causing acute renal failure (38) . We used the CER at the dose of 1.2 g/ kg, which produced severe renal damage at 24 h after the treatment of rats with the antibiotic. In our experiments, such severe injury, which can be seen in the electron micrographs of the renal proximal tubules at 24 h after the treatment of rats with CER, can lead to renal dysfunction. Such severe renal injury may be caused by the ROS. We will attempt to conduct further studies using smaller doses of CER to demonstrate that the CER-derived ROS generation in mitochondria is causing apoptotic cell death in renal cortical cells.
Soltoff has demonstrated that 10 µM rottlerin does not inhibit PKCδ activity in vitro in the presence of diacylglycerol and phosphatidylserine on PC12 cells (39) . Recently, specific inhibitors for various isoforms of PKC have been identified or developed. Among them, rottlerin is found to inhibit PKCδ with specificity (23) . Thus, we employed rottlerin to demonstrate that inhibition of mitochondrial PKCδ activity leading to inhibition of mitochondrial ROS production could suppress the CER-derived nephrotoxicity. To our surprise, results obtained in the present study show that rottlerin inhibits the mitochondrial translocation of PKCδ without clear indication for the inhibition of the translocated mitochondrial PKCδ activity. Thus, the inhibitory effects of rottlerin on PKCδ activity could vary with the types of stimuli applied and also where the rottlerin-inhibitable PKCδ is located. While preliminary, results obtained with rottlerin indicated that it attenuates the CERinduced ROS generation in the mitochondrial fraction of rat renal cortex without significant inhibition of the mitochondrial PKCδ activity. In the absence of the availability of an absolutely specific inhibitor of PKCδ activity, we employed rottlerin, expecting that it will also inhibit mitochondrial ROS production. In contrast to rottlerin, however, the results obtained with H-7, a non-specific but well-known general inhibitor of PKC activity, showed that H-7 inhibited the CER-induced increase of mitochondrial PKC activity as well as the CER-induced overproduction of ROS in mitochondria.
In addition to its ability to inhibit the PKCδ activity, rottlerin has also been reported to be an uncoupler of mitochondrial oxidative phosphorylation and can cause a rapid depletion of ATP level in acinar cells of the parotid gland (39). As we have not measured the rottlerin-derived changes of ATP level in rat renal cortex, we cannot be certain that rottlerin altered the ATP level in rat renal cortex in vivo. In any case, Venkatachalam has demonstrated that a low threshold level of ATP, at best 5 -10% of normal level, can preserve the viability of renal proximal tubule epithelial cells (LLC-PK 1 ) (40) . Some of the unexpected results obtained in the present study may have been caused by some of these non-specific and multi-faceted effects of rottlerin. In future studies, we will try to investigate using other novel and more specific inhibitors of PKCδ as they become available.
While further studies are required to characterize the exact mechanisms involved in the translocation and enhancement of PKC in mitochondria leading to mitochondrial overproduction of ROS, we can take interest in understanding the role of the CER-derived mitochondrial targeting PKCδ as one of the mechanisms involved in the CER-derived nephrotoxicity. This may provide important clues leading to the understanding of molecular mechanisms involved in mitochondrial overproduction of ROS that caused the acute renal failure observed in rats treated with CER.
